Allan A. Young
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Allan A. Young has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Christopher B. Little
The University of Sydney, Sydney Musculoskeletal Health, Sydney, New South Wales, Australia
2 shared publications David H Sonnabend
Raymond Purves Research Laboratory, Institute of Bone and Joint Research, Royal North Shore Hospital, University of Sydney, Pacific Highway, St Leonards, NSW 2065, Australia
2 shared publicationsJames Melrose
Raymond Purves Research Laboratory, Institute of Bone and Joint Research, Royal North Shore Hospital, University of Sydney, Pacific Highway, St Leonards, NSW 2065, Australia
2 shared publicationsMargaret M Smith
Raymond Purves Research Laboratory, Institute of Bone and Joint Research, Royal North Shore Hospital, University of Sydney, Pacific Highway, St Leonards, NSW 2065, Australia
2 shared publicationsMartin A Cake
School of Veterinary and Biomedical Sciences, Murdoch University, South Street, Murdoch, WA 6150, Australia
2 shared publicationsRichard A Read
School of Veterinary and Biomedical Sciences, Murdoch University, South Street, Murdoch, WA 6150, Australia
2 shared publications
Latest Publications
- Open Access
- 31 January 2006
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 8 (2) , R41
Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis
Osteoarthritis is a disease of multifactorial aetiology characterised by progressive breakdown of articular cartilage. In the early stages of the disease, changes become apparent in the superficial zone of articular cartilage, including fibrillation and fissuring. Normally, a monolayer of lubricating molecules is adsorbed on the surface of cartilage and contributes to the minimal friction and wear properties of synovial joints. Proteoglycan 4 is the lubricating glycoprotein believed to be primarily responsible for this boundary lubrication. Here we have used an established ovine meniscectomy model of osteoarthritis, in which typical degenerative changes are observed in the operated knee joints at three months after surgery, to evaluate alterations in proteoglycan 4 expression and localisation in the early phases of the disease. In normal control joints, proteoglycan 4 was immunolocalised in the superficial zone of cartilage, particularly in those regions of the knee joint covered by a meniscus. After the onset of early osteoarthritis, we demonstrated a loss of cellular proteoglycan 4 immunostaining in degenerative articular cartilage, accompanied by a significant (p < 0.01) decrease in corresponding mRNA levels. Early loss of proteoglycan 4 from the cartilage surface in association with a decrease in its expression by superficial-zone chondrocytes might have a role in the pathogenesis of osteoarthritis.
- 31 January 2006
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 8 (2) , R41
Open AccessProteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis
Osteoarthritis is a disease of multifactorial aetiology characterised by progressive breakdown of articular cartilage. In the early stages of the disease, changes become apparent in the superficial zone of articular cartilage, including fibrillation and fissuring. Normally, a monolayer of lubricating molecules is adsorbed on the surface of cartilage and contributes to the minimal friction and wear properties of synovial joints. Proteoglycan 4 is the lubricating glycoprotein believed to be primarily responsible for this boundary lubrication. Here we have used an established ovine meniscectomy model of osteoarthritis, in which typical degenerative changes are observed in the operated knee joints at three months after surgery, to evaluate alterations in proteoglycan 4 expression and localisation in the early phases of the disease. In normal control joints, proteoglycan 4 was immunolocalised in the superficial zone of cartilage, particularly in those regions of the knee joint covered by a meniscus. After the onset of early osteoarthritis, we demonstrated a loss of cellular proteoglycan 4 immunostaining in degenerative articular cartilage, accompanied by a significant (p < 0.01) decrease in corresponding mRNA levels. Early loss of proteoglycan 4 from the cartilage surface in association with a decrease in its expression by superficial-zone chondrocytes might have a role in the pathogenesis of osteoarthritis.
- 1 December 2005
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 87 (12) , 2763-2767
Glycosaminoglycan Content of Knee Cartilage Following Posterior Cruciate Ligament Rupture Demonstrated by Delayed Gadolinium-Enhanced Magnetic Resonance Imaging of Cartilage (dGEMRIC)
Following joint trauma and during the early stages of cartilage degeneration, typical changes become apparent in tissue structure and composition, including the loss of glycosaminoglycan1,2. These changes often are not apparent on conventional magnetic resonance imaging or visible at arthroscopy, thereby precluding diagnosis. Delayed gadolinium-enhanced magnetic resonance imaging of cartilage, or dGEMRIC, is an emerging in vivo method for the assessment of the biochemical composition of articular cartilage and provides a surrogate measure of glycosaminoglycan content3,4. When injected intravenously, the anionic contrast agent gadolinium diethylene triamine penta-acetic acid (Gd-DTPA2–) penetrates cartilage both from the synovial surface and from the subchondral bone3,5. Given sufficient time, the anionic contrast agent distributes inversely to the fixed negative charge associated with the cartilage glycosaminoglycan content in accordance with the Donnan principle of equilibrium. Gd-DTPA2-therefore distributes in relatively higher concentrations in regions of low glycosaminoglycan, and vice versa. Gd-DTPA2-has a concentration-dependent effect on the magnetic resonance imaging parameter T1; therefore, T1 imaging in the presence of Gd-DTPA2– (T1Gd) reflects the cartilage Gd-DTPA2–concentration and, hence, glycosaminoglycan concentration. We present the case of a patient (one of the authors [A.A.Y.]) who sustained an injury to the posterior cruciate ligament of the knee while enrolled as a “normal” control subject in a dGEMRIC study of the knee. This incidental occurrence provided us with a unique opportunity to visualize the temporal and spatial changes that occur in cartilage biochemistry following an acute posterior cruciate ligament rupture. Athirty-year-old man (one of the authors [A.A.Y.]) was involved in a motor-vehicle accident in which he sustained a direct blow to the anterior aspect of the proximal portion of the right tibia at 90° of knee flexion (a typical “dashboard” type of …
- 1 December 2005
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 87 (12) , 2763-2767
Glycosaminoglycan Content of Knee Cartilage Following Posterior Cruciate Ligament Rupture Demonstrated by Delayed Gadolinium-Enhanced Magnetic Resonance Imaging of Cartilage (dGEMRIC)
Following joint trauma and during the early stages of cartilage degeneration, typical changes become apparent in tissue structure and composition, including the loss of glycosaminoglycan1,2. These changes often are not apparent on conventional magnetic resonance imaging or visible at arthroscopy, thereby precluding diagnosis. Delayed gadolinium-enhanced magnetic resonance imaging of cartilage, or dGEMRIC, is an emerging in vivo method for the assessment of the biochemical composition of articular cartilage and provides a surrogate measure of glycosaminoglycan content3,4. When injected intravenously, the anionic contrast agent gadolinium diethylene triamine penta-acetic acid (Gd-DTPA2–) penetrates cartilage both from the synovial surface and from the subchondral bone3,5. Given sufficient time, the anionic contrast agent distributes inversely to the fixed negative charge associated with the cartilage glycosaminoglycan content in accordance with the Donnan principle of equilibrium. Gd-DTPA2-therefore distributes in relatively higher concentrations in regions of low glycosaminoglycan, and vice versa. Gd-DTPA2-has a concentration-dependent effect on the magnetic resonance imaging parameter T1; therefore, T1 imaging in the presence of Gd-DTPA2– (T1Gd) reflects the cartilage Gd-DTPA2–concentration and, hence, glycosaminoglycan concentration. We present the case of a patient (one of the authors [A.A.Y.]) who sustained an injury to the posterior cruciate ligament of the knee while enrolled as a “normal” control subject in a dGEMRIC study of the knee. This incidental occurrence provided us with a unique opportunity to visualize the temporal and spatial changes that occur in cartilage biochemistry following an acute posterior cruciate ligament rupture. Athirty-year-old man (one of the authors [A.A.Y.]) was involved in a motor-vehicle accident in which he sustained a direct blow to the anterior aspect of the proximal portion of the right tibia at 90° of knee flexion (a typical “dashboard” type of …
- Open Access
- 12 May 2005
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 7 (4) , R852-61
Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis
Osteoarthritis (OA), the commonest form of arthritis and a major cause of morbidity, is characterized by progressive degeneration of the articular cartilage. Along with increased production and activation of degradative enzymes, altered synthesis of cartilage matrix molecules and growth factors by resident chondrocytes is believed to play a central role in this pathological process. We used an ovine meniscectomy model of OA to evaluate changes in chondrocyte expression of types I, II and III collagen; aggrecan; the small leucine-rich proteoglycans (SLRPs) biglycan, decorin, lumican and fibromodulin; transforming growth factor-β; and connective tissue growth factor. Changes were evaluated separately in the medial and lateral tibial plateaux, and were confirmed for selected molecules using immunohistochemistry and Western blotting. Significant changes in mRNA levels were confined to the lateral compartment, where active cartilage degeneration was observed. In this region there was significant upregulation in expession of types I, II and III collagen, aggrecan, biglycan and lumican, concomitant with downregulation of decorin and connective tissue growth factor. The increases in type I and III collagen mRNA were accompanied by increased immunostaining for these proteins in cartilage. The upregulated lumican expression in degenerative cartilage was associated with increased lumican core protein deficient in keratan sulphate side-chains. Furthermore, there was evidence of significant fragmentation of SLRPs in both normal and arthritic tissue, with specific catabolites of biglycan and fibromodulin identified only in the cartilage from meniscectomized joints. This study highlights the focal nature of the degenerative changes that occur in OA cartilage and suggests that altered synthesis and proteolysis of SLRPs may play an important role in cartilage destruction in arthritis.
- 12 May 2005
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 7 (4) , R852-61
Open AccessRegional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis
Osteoarthritis (OA), the commonest form of arthritis and a major cause of morbidity, is characterized by progressive degeneration of the articular cartilage. Along with increased production and activation of degradative enzymes, altered synthesis of cartilage matrix molecules and growth factors by resident chondrocytes is believed to play a central role in this pathological process. We used an ovine meniscectomy model of OA to evaluate changes in chondrocyte expression of types I, II and III collagen; aggrecan; the small leucine-rich proteoglycans (SLRPs) biglycan, decorin, lumican and fibromodulin; transforming growth factor-β; and connective tissue growth factor. Changes were evaluated separately in the medial and lateral tibial plateaux, and were confirmed for selected molecules using immunohistochemistry and Western blotting. Significant changes in mRNA levels were confined to the lateral compartment, where active cartilage degeneration was observed. In this region there was significant upregulation in expession of types I, II and III collagen, aggrecan, biglycan and lumican, concomitant with downregulation of decorin and connective tissue growth factor. The increases in type I and III collagen mRNA were accompanied by increased immunostaining for these proteins in cartilage. The upregulated lumican expression in degenerative cartilage was associated with increased lumican core protein deficient in keratan sulphate side-chains. Furthermore, there was evidence of significant fragmentation of SLRPs in both normal and arthritic tissue, with specific catabolites of biglycan and fibromodulin identified only in the cartilage from meniscectomized joints. This study highlights the focal nature of the degenerative changes that occur in OA cartilage and suggests that altered synthesis and proteolysis of SLRPs may play an important role in cartilage destruction in arthritis.